|
|
| Line 1: |
Line 1: |
| | | | |
| | ==A consensus human beta defensin== | | ==A consensus human beta defensin== |
| - | <StructureSection load='6mjv' size='340' side='right'caption='[[6mjv]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | + | <StructureSection load='6mjv' size='340' side='right'caption='[[6mjv]]' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[6mjv]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6MJV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6MJV FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6mjv]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6MJV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6MJV FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6mjv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6mjv OCA], [http://pdbe.org/6mjv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6mjv RCSB], [http://www.ebi.ac.uk/pdbsum/6mjv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6mjv ProSAT]</span></td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6mjv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6mjv OCA], [https://pdbe.org/6mjv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6mjv RCSB], [https://www.ebi.ac.uk/pdbsum/6mjv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6mjv ProSAT]</span></td></tr> |
| | </table> | | </table> |
| | <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| Line 15: |
Line 15: |
| | </div> | | </div> |
| | <div class="pdbe-citations 6mjv" style="background-color:#fffaf0;"></div> | | <div class="pdbe-citations 6mjv" style="background-color:#fffaf0;"></div> |
| | + | |
| | + | ==See Also== |
| | + | *[[Defensin 3D structures|Defensin 3D structures]] |
| | == References == | | == References == |
| | <references/> | | <references/> |
| | __TOC__ | | __TOC__ |
| | </StructureSection> | | </StructureSection> |
| | + | [[Category: Homo sapiens]] |
| | [[Category: Large Structures]] | | [[Category: Large Structures]] |
| - | [[Category: Amero, C]] | + | [[Category: Amero C]] |
| - | [[Category: Corzo, G]] | + | [[Category: Corzo G]] |
| - | [[Category: Norton, R S]] | + | [[Category: Norton RS]] |
| - | [[Category: Rodriguez, A]] | + | [[Category: Rodriguez A]] |
| - | [[Category: Villegas-Moreno, J]] | + | [[Category: Villegas-Moreno J]] |
| - | [[Category: Antimicrobial protein]]
| + | |
| - | [[Category: Human beta-defensin]]
| + | |
| Structural highlights
Publication Abstract from PubMed
The spread of multidrug resistant bacteria owing to the intensive use of antibiotics is challenging current antibiotic therapies, and making the discovery and evaluation of new antimicrobial agents a high priority. The evaluation of novel peptide sequences of predicted antimicrobial peptides from different sources is valuable approach to identify alternative antibiotic leads. Two strategies were pursued in this study to evaluate novel antimicrobial peptides from the human beta-defensin family (hBD). In the first, a 32-residue peptide was designed based on the alignment of all available hBD primary structures, while in the second a putative 35-residue peptide, hBD10, was mined from the gene DEFB110. Both hBDconsensus and hBD10 were chemically synthesized, folded and purified. They showed antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Mycobacterium tuberculosis, but were not hemolytic on human red blood cells. The NMR-based solution structure of hBDconsensus revealed that it adopts a classical beta-defensin fold and disulfide connectivities. Even though the mass spectrum of hBD10 confirmed the formation of three disulfide bonds, it showed limited dispersion in (1) H NMR spectra and structural studies were not pursued. The evaluation of different beta-defensin structures may identify new antimicrobial agents effective against multidrug-resistant bacterial strains.
Antimicrobial activity and structure of a consensus human beta-defensin and its comparison to a novel putative hBD10.,Rodriguez A, Pedersen MO, Villegas E, Rivas-Santiago B, Villegas-Moreno J, Amero C, Norton RS, Corzo G Proteins. 2019 Jul 20. doi: 10.1002/prot.25785. PMID:31325337[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Rodriguez A, Pedersen MO, Villegas E, Rivas-Santiago B, Villegas-Moreno J, Amero C, Norton RS, Corzo G. Antimicrobial activity and structure of a consensus human beta-defensin and its comparison to a novel putative hBD10. Proteins. 2019 Jul 20. doi: 10.1002/prot.25785. PMID:31325337 doi:http://dx.doi.org/10.1002/prot.25785
|
